European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Second HMA/EMA multi-stakeholder forum on EudraVigilance and signal detection, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 December 2026, 09:00 (CET) to 1 December 2026, 17:30 (CET)

Second HMA/EMA multi-stakeholder forum on EudraVigilance and signal detection, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 December 2026, 09:00 (CET) to 1 December 2026, 17:30 (CET)

DARWIN EU Advisory Board meeting: 14 November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 November 2025, 09:00 (CET) to 14 November 2025, 13:00 (CET)

DARWIN EU Advisory Board meeting: 14 November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 November 2025, 09:00 (CET) to 14 November 2025, 13:00 (CET)

Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 14, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness